Plasma homocysteine in women taking hormone replacement therapy: The postmenopausal Estrogen/Progestin Interventions (PEPI) trial

Journal of Women's Health and Gender-Based Medicine

Volumn 8, Issue 9, 1999, Pages 1167-1172

  Barnabei, Vanessa M ^a,b   Phillips, Terry M ^a   Hsia, Judith ^a  

^a GEORGE WASHINGTON UNIVERSITY   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONJUGATED ESTROGEN; FOLIC ACID; GESTAGEN; HOMOCYSTEINE; PLACEBO; VITAMIN B GROUP;

ADULT; AGED; AMINO ACID BLOOD LEVEL; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ESTROGEN THERAPY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0032741765     PISSN: 15246094     EISSN: None     Source Type: Journal    
DOI: 10.1089/jwh.1.1999.8.1167     Document Type: Article

References (17)

1. Graham IA, Daly LE, Refsum HM, et al. Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Profect. JAMA 1997;277: 1775.
2. Kuller LH, Evans RW. Homocysteine, vitamins and cardiovascular disease. Circulation 1998;98:196.
3. Nygard O, Hordrehaug JE, Refsum H, Ueland PM, Farstad M, Vollset SE. Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med 1997;337:230.
4. Wald NJ, Laaw MR, Weir DG, McPartlin J, Scott JM. Homocysteine and ischemic heart disease: Results of a prospective study with implications regarding prevention. Arch Intern Med 1998;158:862.
5. Kang SS, Wong PWK, Cook HY, Norusis M, Messer JV. Protein-bound homocyst(e)ine: A possible risk factor for coronary artery disease. J Clin Invest 1986; 77:1482.
6. Kluijtmans LAJ, van den Heuvel LPWJ, Boers GHJ, et al. Molecular genetic analysis in mild hyperhomocysteinemia: A common mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease. Am J Hum Genet 1996;58:35.
7. Folsom AR, Nieto J, McGovern PG, et al. Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms, and B vitamins. The Atherosclerosis Risk in Communities (ARIC) Study. Circulation 1998;98: 204.
8. 6 from diet and supplements in relation to risk of coronary heart disease among women. JAMA 1998;279:359.
9. Wouters MG, Moorrees MT, van der Mooren MJ, et al. Plasma homocysteine and menopausal status. Eur J Clin Invest 1995;25:801.
10. Grady D, Rubin SM, Petitti DB, et al. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med 1992;117:1016.
11. Hulley S, Grady D, Bush T, et al., for the Heart and Estrogen/Progestin Replacement Study (HERS) Research Group. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA 1998;280: 605.
12. Giltay EJ, Hoogeveen EK, Elberts JM, Gooren LJ, Asscheman H, Stehouwer CD. Effects of sex steroids on plasma total homocysteine levels: A study in transsexual males and females. J Clin Endocrinol Metab 1998;83:550.
13. Mijatovic V, Kenemans P, Jakobs C, van Baal WM, Peters-Muller ER, van der Mooren MJ. A randomized controlled study of the effects of 17beta-estradiol-dydrogesterone on plasma homocysteine in post-menopausal women. Obstet Gynecol 1998;91:432.
14. van der Mooren MJ, Demacker PN, Blom HJ, de Rijke YB, Rolland R. The effect of sequential three-monthly hormone replacement therapy on several cardiovascular risk estimators in postmenopausal women. Fertil Steril 1997;67:67.
15. Green TJ, Houghton LA, Donovan U, Gibson RS, O'Connor DL. Oral contraceptives did not affect biochemical folate indexes and homocysteine concentrations in adolescent females. J Am Diabetic Assoc 1998; 98:49.
16. The Writing Group for the PEPI Trial. Effects of estrogen or estrogen-progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. JAMA 1995;273:199.
17. Araki A, Sako Y. Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection. J Chromatogr 1987;422:43.